Articles > Popular publications > PR Newswire press releases > October-December 2006 > Monday, November 20

Article: Genmab Licenses MIF Receptor Target From Cytokine PharmaSciences.

Article from:
PR Newswire
Article date:
November 20, 2006
Copyright

COPENHAGEN, Denmark and KING OF PRUSSIA, Pa., Nov. 20 /PRNewswire-FirstCall/ -- Genmab A/S and Cytokine PharmaSciences, Inc. announced today that Genmab has licensed rights to the MIF receptor target from Cytokine PharmaSciences. Genmab intends to develop therapeutic human antibodies to the licensed target. Details of the agreement were not disclosed.

"We are enthusiastic about this target, especially as there has been positive proof of concept data in experimental animal models," said Lisa N. Drakeman, Ph.D., Chief Executive Officer of Genmab.

Denny Willson, president and CEO of Cytokine PharmaSciences, stated: "Genmab is a world-class company in ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: Genmab licenses MIF from Cytokine ...
Pharma Marketletter;  November 27, 2006 ;     576 words ...Danish biotechnology company Genmab AS says that it has licensed rights ... inhibitory factor (MIF) receptor from Cytokine PharmaSciences of the USA. MIF is a pro-inflammatory ... activate T cells and macrophages. Genmab said that it intends to develop ...

Article: Cytokine PharmaSciences, Inc. Issued Patent for MIF ...
PR Newswire;  May 3, 2007 ;     700+ words ... ... PRNewswire/ -- Cytokine PharmaSciences, Inc. (CPSI ... antibodies to Genmab, A/S. CPSI ... President and CEO of Cytokine PharmaSciences, stated ... therapeutics." Cytokine PharmaSciences is a biopharmaceutical ...

Article: CYTOKINE PHARMASCIENCES SIGNS BAXTER TO MIF ...
BIOWORLD Today;  March 14, 2003 ;     700+ words ... ... Sticking close to its business plan, Cytokine PharmaSciences Inc. is farming out antibody ... financial terms were not disclosed, Cytokine PharmaSciences will receive money that it called ... standpoint," Dennis Willson, Cytokine PharmaSciences' president and CEO, told BioWorld ...

Article: Cytokine PharmaSciences Completes Phase I Study of ...
PR Newswire;  November 30, 2009 ;     700+ words ... ... Nov. 30 /PRNewswire/ -- Cytokine PharmaSciences, Inc. today announced the completion ... of Preclinical Development at Cytokine PharmaSciences. "We have also established a ... activity of CPSI-2364. About Cytokine PharmaSciences Cytokine PharmaSciences, Inc ...

Article: Cytokine PharmaSciences Initiates Phase I Study of ...
PR Newswire;  July 20, 2009 ;     700+ words ... ... July 20 /PRNewswire/ -- Cytokine PharmaSciences, Inc. today announced the initiation ... Willson, president and CEO of Cytokine PharmaSciences. "As a small molecule, CPSI ... activity of CPSI-2364. About Cytokine PharmaSciences Cytokine PharmaSciences, Inc ...

Article: Cytokine PharmaSciences Licenses Anti-MIF ...
PR Newswire;  March 13, 2003 ;     666 words ... ... March 13 /PRNewswire/ -- Cytokine PharmaSciences, Inc. has signed an exclusive ... Willson, president and CEO of Cytokine PharmaSciences. "Baxter is a top-tier player ... anti-MIF product to market." Cytokine PharmaSciences is a biopharmaceutical development ...

Article: Cytokine PharmaSciences Announces Retirement of ...
PR Newswire;  January 7, 2005 ;     670 words ... ... Jan. 7 /PRNewswire/ -- Cytokine PharmaSciences, Inc. today announced the retirement ... Willson, president and CEO of Cytokine PharmaSciences, stated: "Richard is a classic ... where he worked until founding Cytokine PharmaSciences in 1992. Cytokine PharmaSciences ...

Article: Marillion Pharmaceuticals and Cytokine ...
Business Wire;  February 25, 2008 ;     700+ words ... ... and Sjogren's Syndrome from Cytokine PharmaSciences MALVERN, Pa. & KING OF ... Marillion Pharmaceuticals Inc and Cytokine PharmaSciences Inc (CPSI) announced today that ... Business Development, CPSI. "As Cytokine PharmaSciences continues to progress its pipeline ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives